Annual Cash & Cash Equivalents
$3.37 M
-$16.27 M-82.85%
December 31, 2023
Summary
- As of March 6, 2025, INKT annual cash & cash equivalents is $3.37 million, with the most recent change of -$16.27 million (-82.85%) on December 31, 2023.
- During the last 3 years, INKT annual cash & cash equivalents has risen by +$676.00 thousand (+25.12%).
- INKT annual cash & cash equivalents is now -91.34% below its all-time high of $38.89 million, reached on December 31, 2021.
Performance
INKT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.33 M
-$2.99 M-32.05%
September 30, 2024
Summary
- As of March 6, 2025, INKT quarterly cash and cash equivalents is $6.33 million, with the most recent change of -$2.99 million (-32.05%) on September 30, 2024.
- Over the past year, INKT quarterly cash and cash equivalents has stayed the same.
- INKT quarterly cash and cash equivalents is now -83.73% below its all-time high of $38.89 million, reached on December 31, 2021.
Performance
INKT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INKT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.8% | 0.0% |
| 3 y3 years | +25.1% | 0.0% |
| 5 y5 years | +1026.2% | 0.0% |
INKT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.3% | at low | -83.7% | +87.9% |
| 5 y | 5-year | -91.3% | +1026.2% | -83.7% | +672.2% |
| alltime | all time | -91.3% | +1026.2% | -83.7% | +672.2% |
MiNK Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.33 M(-32.1%) |
| Jun 2024 | - | $9.31 M(+60.1%) |
| Mar 2024 | - | $5.82 M(+72.8%) |
| Dec 2023 | $3.37 M(-82.9%) | $3.37 M(-47.4%) |
| Sep 2023 | - | $6.40 M(-39.8%) |
| Jun 2023 | - | $10.62 M(-28.7%) |
| Mar 2023 | - | $14.89 M(-24.2%) |
| Dec 2022 | $19.64 M | $19.64 M(-18.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $24.16 M(-19.1%) |
| Jun 2022 | - | $29.85 M(-14.0%) |
| Mar 2022 | - | $34.69 M(-10.8%) |
| Dec 2021 | $38.89 M(+1345.0%) | $38.89 M(+4645.4%) |
| Sep 2021 | - | $819.50 K(-50.6%) |
| Jun 2021 | - | $1.66 M(-38.4%) |
| Dec 2020 | $2.69 M(+800.1%) | $2.69 M |
| Dec 2019 | $299.00 K | - |
FAQ
- What is MiNK Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MiNK Therapeutics?
- What is MiNK Therapeutics annual cash & cash equivalents year-on-year change?
- What is MiNK Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly cash and cash equivalents year-on-year change?
What is MiNK Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of INKT is $3.37 M
What is the all time high annual cash & cash equivalents for MiNK Therapeutics?
MiNK Therapeutics all-time high annual cash & cash equivalents is $38.89 M
What is MiNK Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, INKT annual cash & cash equivalents has changed by -$16.27 M (-82.85%)
What is MiNK Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INKT is $6.33 M
What is the all time high quarterly cash and cash equivalents for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly cash and cash equivalents is $38.89 M
What is MiNK Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, INKT quarterly cash and cash equivalents has changed by $0.00 (0.00%)